ClinicalTrials.gov
public full text
Public Domain
Saliva-based Detection of CD44
The purpose of this study is to test the ability of OncAlert™ to screen for cancer and the reappearance of cancer. OncAlert™ was developed by Vigilant Biosciences, a collaborator in this research study. OncAlert™ is an oral rinse which is spit into a cup and sent to a laboratory for analysis. OncAlert™ is considered experimental by the FDA because it is not approved for the screening of cancer.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Determination and Validation of a Multi-analyte Assay for Lung Cancer Screening#887899
- Evaluation of Fecal Multi-target Biomarkers in the Screening of Digestive Tract Cancers#1056951
- Diagnosis of Cancer Using Breath Samples#1102389
- Oral Margin Spectroscopy Detection Using Optical Spectroscopy#1008752
- Volatile Organic Compounds as Breath Biomarkers in Squamous Oesophageal Neoplasms#876128
Record · ID 1095416
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive